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1 Introduction
Systems biology aims to understand biochemical processes holistically by means
of mathematical models. They enable extensive analysis of complex biological
systems. For example in cancer research, mathematical models can generate
prognoses for the growth and behaviour of tumors under medical treatment.
This can reduce the gap of therapeutic efficacy between in vitro experiments
and real world patient treatment.
Mostly, tumor cells can be killed by inducing apoptosis. TRAIL, a potential
tumor therapeutic induces apoptosis via triggering of death receptors. It is a
potential therapeutic because TRAIL induces apoptosis exclusively in abnormal
cells. However, cell populations in three-dimensional shapes, as multicellular
tumor spheroids, show an increased resistance to medical treatment compared
to two-dimensional ones. This phenomena is called multicellular resistance and
occurs during treatment with drugs including TRAIL.
The profound understanding of the mechanisms in a tumor spheroid under
treatment with TRAIL and their relevance for the development of the resistance
could explain this phenomena. There are three characteristics of tumor spheroids
which are regarded possible reasons:
1. Heterogeneous distribution of TRAIL in spheroids, especially reduced
concentration in the center due to limited diffusion,
2. heterogeneity of tumor cells in the spheroid, proliferating, quiescent and
necrotic cells occur due to limited nutrient supply,
3. intercellular communication, which increases anti-apoptotic signals.
A mathematical model could derive which characteristics are decisive for the
development of resistance.
This work is split in two parts. The first part “Propaedeuticum” presents
background information concerning cancer and mathematical modeling in cancer
research in form of a review on actual and historical models considering three-
dimensionality. In the second part, the Bachelor thesis “Modeling and simulation
of a three-dimensional tumor spheroid” is presented. The thesis focuses on
modeling and simulating the first and the second of the above mentioned
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characteristics. A theoretical model is derived in Chapter 5 which represents
a tumor spheroid under treatment with TRAIL. The diffusion of TRAIL and
nutrients into the spheroid is modeled in Section 5.2, as well as the intracellular
reaction to TRAIL stimulation and glucose uptake, see Section 5.3. The
theoretical model is implemented by extending an agent-based simulation
framework by Imig et al. (2015) by a third dimension. Following, the in
silico model is analyzed regarding validity and computing capacity. At last, a
population under treatment with TRAIL is simulated in three dimensions. The
results are analyzed and compared to the two-dimensional case.
2
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Propaedeuticum
3

2 Biological Background
Cancer therapy is an important and interesting research area in systems biology,
in which potential drugs are analyzed via mathematical models. Since in the
following chapter the modeling of tumor spheroids under medical treatment is
discussed, it is essential to regard the biological processes of cancer in detail.
Therefore, the first section presents development and structure of a tumor.
Afterwards, the pathway of apoptosis and TRAIL (TNF-related apoptosis-
inducing ligand), a potential therapeutic agent, are regarded with focus on their
function in cancer therapy.
2.1 Tumor Formation
Cancer is associated with genetic alterations, which disrupt cell control mecha-
nisms and lead to an increased proliferation rate. The affected genes are divided
into two classes: proto-oncogenes and tumor suppressor genes. Usually, the
protein products of proto-oncogenes stimulate cell proliferation. But proto-
oncogenes can mutate into oncogenes which protein product’s promote tumor
growth. In addition, mutations of tumor suppressor genes, which normally
signal for cell-cycle arrest or induce apoptosis, result in dysfunction of protein
products causing tumor growth. For further information on deregulation of the
cell cycle in cancer, Vermeulen et al. (2003) is recommended.
The appearance of such mutations can lead to cells with an increased prolif-
eration rate which form an early tumor, called an avascular tumor. Since an
avascular tumor only receives nutrients from surroundings by diffusion, its size is
restricted to 400− 600µm in diameter (Nyga et al., 2011). With increasing size
the amount of nutrients reaching the tumor center declines. When the nutrient
amount is too low to sustain the cells in the tumor center, they die and form a
necrotic core. Moreover, a layer of quiescent cells separates the nutrient-starved
necrotic core from a layer of proliferating cells on the outside (Sutherland et al.,
1986). The general structure of an avascular tumor is illustrated in Figure 2.1.
If the tumor gets vascularized, during a process of angiogenesis, in which
blood vessels from adjacent vasculature grow, it gets access to nutrient source
via blood circulation. The vascular tumor grows fast and can get a huge size. So
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called invasive tumors, which grow into surrounding structures like vasculature,
can cause metastasis (Folkman, 1974).
proliferating rim
layer with quiescent 
cells
necrotic core
r
Figure 2.1: Schematic cross section of a fully-developed avascular tumor (right
figure) in comparison to a central cross section of an in vitro spheroid (left
figure). An outer rim of proliferating cells surrounds a layer of quiescent cells
and a central core of necrotic cells. Left figure taken from Sutherland et al.
(1986).
2.2 Pathway of Apoptosis
Apoptosis is a highly-regulated process of programmed cell death during which,
in contrast to necrosis, no damage for the surrounding tissue occurs. It can
be initiated by various intrinsic and extrinsic inducers. DNA-damage (e.g. via
UV-irradiation or chemotherapy), the loss of control over cell cycle and many
other internal checkpoints of cell cycle stimulate the cell-intrinsic pathway. In
contrast, the cell-extrinsic pathway of apoptosis is stimulated by the triggering
of death receptors (DRs) (e.g. via TRAIL or T-killer cells), the loss of survival
signals by growth factors and the loss of surrounding cells (Kerr et al., 1994).
Figure 2.2 illustrates the cell-extrinsic and cell-intrinsic pathways of apoptosis.
Following initiation of the cell-extrinsic pathway, cytoplasmic proteins in-
cluding the adaptor protein FADD (Fas-associated death domain) form a
death-inducing complex (DISC) at the death domain of the receptor. Hereupon,
procaspase 8 is recruited to the DISC, autoactivates by proteolysis and acti-
vates procaspase 10 by cleaving it. Activated initiator caspases 8 and 10 cleave
6
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Figure 2.2: Activation of the cell-extrinsic and cell-intrinsic apoptosis pathways
by Apo2L/TRAIL. Taken from Almasan & Ashkenazi (2003).
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procaspases 3, 6 and 7 which work in activated form as effector caspases.
The exact procedure of apoptosis depends on the cell type. In cells of
type I, activation of the extrinsic pathway is sufficient to activate the effector
caspases and cause apoptosis. In contrast, in cells of type II execution of
apoptosis depends on the indirectly activated intrinsic pathway and the resulting
amplification of death signal.
The intrinsic pathway is on the one hand indirectly activated by initiator
caspases cleaving Bid, a pro-apoptotic member of the Bcl-2 family. Cleaved
Bid translocates to the mitochondria and activates Bax and Bak, pro-apoptotic
members of the Bcl-2 family. On the other hand, cell-internal apoptosis initiators
like DNA-damage enhance the expression of tumor suppressor gene p53 which
activates Bax and Bak. Activation of Bax and Bak leads to the release of the
signaling molecule cytochrome c from the mitochondrion. Bax and Bak are
counteracted by anti-apoptotic members of the Bcl-2 and Bcl-XL family. The
binding of cytoplasmic cytochrome c to the protein Apaf-1 initiates the formation
of an apoptosome. Following, procaspase 9 is recruited to the apoptosome and
activated. Caspase 9 activates procaspases 3, 6 and 7 as well as procaspases 8
and 10. The effector caspases are binded and inhibited by inhibitor of apotosis
proteins (IAPs) which in turn are inhibited by Smac/Diablo released from the
mitochondrion (Almasan & Ashkenazi, 2003).
Effector caspases activated in course of cell-extrinsic or cell-intrisic pathway,
trigger the following degradation of the cell. Condensation of chromatin, DNA-
laddering, cell shrinkage and formation of apoptotic bodies, finally lead to a
total phagocytosis of the cell (Kerr et al., 1994).
2.3 The Potential Therapeutic TRAIL
TRAIL is a potential tumor-specific cancer therapeutic because it induces
cell death, more precisely apoptosis, selectively in transformed cells. The
induction of apoptosis through TRAIL works by engagement of death receptors
which initiates the cell-extrinsic pathway. Two of the receptors which bind
TRAIL are pro-apoptotic, DR4 and DR5. The other three receptors, Decoy
receptor 1 (DcR1), DcR2 and osteoprotegerin (OPG), act as “decoys” since
their extracellular domains are homologous to death receptor domains but the
receptors are not capable of transmitting a pro-apoptotic signal (Almasan &
Ashkenazi, 2003). Figure 2.3 gives an overview of the five TRAIL receptors.
As a result of the above represented characteristics, the potential of TRAIL
as cancer therapeutic is promising. While most therapeutics, as chemotherapy,
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target on initiation of the intrinsic pathway, TRAIL initiates the extrinsic
pathway. Further, most DNA-damaging drugs, like chemotherapy, require
the function of tumor suppressor p53, whereas in most human cancers p53 is
inactivated after following tumor progression or as a result of clinical treatments
(Almasan & Ashkenazi, 2003). This inactivation of p53 results in a resistance
to chemotherapy and as consequence all therapeutics targeting the intrinsic
pathway are failing in therapy.
In conclusion, TRAIL can trigger apoptosis independent of the tumor sup-
pressor p53 and therefore avoid the resistance. A combination of TRAIL and
chemotherapy might lead to synergistic apoptosis activation and an effective tu-
mor treatment. For further dicussion on TRAIL’s potential for cancer research,
Almasan & Ashkenazi (2003) is recommended.
Figure 2.3: TRAIL receptors and their function. Figure taken from Almasan
& Ashkenazi (2003).
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3 Three-dimensional Models of Tumor
Spheroids
In this chapter, models of three-dimensional tumor spheroids are presented.
The first section discusses experimental in vitro and in vivo models. In the
following section, in silico models are reviewed with focus on three-dimensional
models.
3.1 Experimental Models
To calibrate and validate a mathematical model or test potential cancer
therapeutics, as TRAIL, in experiments, an adequate in vitro model of tumors
is important. Research on molecular and genetic mechanism of cancer has
widely used two-dimensional models like monolayers. Monolayers are single-cell
layers grown on a flat medium.
So called in vivo models, as human tumor xenografts, mimic the morpho-
logical characteristics and the in situ environment of a tumor better than
two-dimensional in vitro models. However, since those tumors are grown in
living mice, it is a challenge to observe its behaviour under medical treatment.
So far, most efforts to translate results of xenograft models to the clinic failed
(Nyga et al., 2011).
A three-dimensional in vitro model is an important alternative to two-
dimensional models and in vivo models. Multicellular tumor spheroids (MCTSs)
have proved appropriate (Friedrich et al., 2007). Many culture methods have
been developed to generate MCTS, which are thereby easy to generate and
therefore applicable in experimental research. One method aims to generate
spheroids as hanging drops, wherein the cells can grow together. Their complex-
ity ranges from MCTS consisting of a single cell line to MCTS which include
multiple cell types. In addition, there are approaches to equip MCTS with
proper extracellular matrix (ECM). Some are presented in Nyga et al. (2011). A
MCTS mimics micrometastases, avascular microtumors or intercapillary tumor
microregions. Further the development of rims and the appearance of concen-
tration gradients can be observed analogously to solid tumors as imaged in
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Figure 3.1: Multicellular tumor spheroids display growth characteristics and
numerous pathophysiological features of avascular microtumors and developing
micrometastases and also inside out resemble the situation from intercapillary
tumor microregions. Taken from Friedrich et al. (2007).
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Figure 3.1. A detailed discussion of the suitability of MCTS as in vitro model
can be found in Friedrich et al. (2007).
Recent experiments with three-dimensional models showed an increased
resistance to medical treatment compared to experimental results with two-
dimensional models (Fessl, 2013). To understand underlying processes and the
reasons for the development of this resistance, MCTSs are used for the current
research.
3.2 In Silico Modeling Approaches
This section focuses on in silico models considering three-dimensionality of
tumor spheroids. Chronologically, Shymko & Glass (1976) and Greenspan
(1976) presented the first three-dimensional models of tumor spheroids (Araujo
& McElwain, 2004). Both attempted to predict the growth pattern of tumor
spheroids and to reveal essential mechanisms of tumor growth. Shymko & Glass
(1976) extended a one-dimensional, schematic model describing the growth
and development of a tumor including effects of growth inhibitors. Their
three-dimensional model predicted the effect of the three-dimensional shape on
stability of the spheroid during growth. Self-limiting growth in three dimensions
in contrast to unlimited growth of two-dimensional populations was shown.
The model of Greenspan (1976) includes various important phenomena derived
in experimental work by Sutherland et al. (1986), such as the existence of a
steady-state size, the development of a necrotic core due to limited nutrient
supply and cell movement inside the spheroid. The model by Greenspan (1976)
predicted stability of a spheroid to external, assymetric pertubations. It was
shown that an aggregate of cells becomes less stable with increasing size. In
addition, a function of two model parameters was derived predicting weather or
not a steady state size is reached before external pertubations predominate. The
parameters were dependent of surface tension, external nutrient concentration,
rate of volume loss due to necrosis and rates of proliferation and consumption.
Today, various in silico models of tumor spheroids exist focusing on the growth
and development of avascular (Schaller & Meyer-Hermann, 2005; Galle et al.,
2005; Kim et al., 2007) and vascular tumor spheroids (Shirinifard et al., 2009),
angiogenesis (Shirinifard et al., 2009), cell migration in a spheroid (Schaller &
Meyer-Hermann, 2006) or metastasis and tumor invasion (Stein et al., 2007).
Different approaches for modeling tumor spheroids have been developed.
They can mainly be structured by their choice of mathematical equipment
into three main areas: continuum models, discrete models and hybrid models.
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Whereas in continuum models partial differential equations (PDEs) are used to
represent tumor spheroids, discrete models use ordinary differential equations
(ODEs). The hybrid model type combines PDEs and ODEs to profit from both
advantages.
Discrete models can represent the heterogeneity of individual cells as well as
their interaction. Most simulation frameworks using ODEs are individual-based
and implemented with a fixed spatial grid. Models using merely ODEs fail in
representing a realistic shape of the spheroid and important fluid dynamics
inside (Byrne et al., 2006).
In contrast, continuum models are able to represent spatial dynamics as
tumor cell density and concentration of nutrient distribution. By means of
fluid and continuum mechanic principles, the diffusive transport of substrates
in the extracellular space of the tumor spheroid can be modeled. However,
continuum models cannot consider the discreteness of cells and tumor structures
(Byrne, 2012). Schaller & Meyer-Hermann (2006) present a continuum model of
avasular tumor spheroids assumed spherical symmetric. It describes densities of
viable and necrotic cells as well as concentration of glucose and oxygen inside
the spheroid. Their model is compared to an analogous, lattice-free agent-based
model (ABM) regarding growth properties. For further reading on continuum
models, the review of Byrne (2012) is recommended.
The hybrid model type combines ODEs and PDEs to benefit from both
advantages. It is able to represent most phenomena and interactions across
multiple space and time scales relevant for cancer. Rejniak & Anderson (2010) is
recommended for a detailed review on hybrid models of tumor spheroids. ABMs
are an example for a hybrid simulation framework. They can be structured in
on-lattice ones using a fixed spatial grid and off-lattice ones disclaiming a grid.
In on-lattice models, the positions of cells are fixed on the spatial grid, whereas
in off-lattice ones cells are able to move free from fixed positions. For review
on ABM, Zhang et al. (2008) is recommended. For example, Shirinifard et al.
(2009) use a Potts model which is agent-based. It represents tumor growth
and angiogenesis in three dimensions. The Potts model is an extension of the
widely-used Cellular Automaton approach (CA) which uses a regular, fixed grid,
e.g. a square, hexagonal or cubical grid. Each grid site in CA contains one
or more cells. In contrast, in Potts model one cell ranges over multiple grid
sites enabling a more detailed representation of the shape of individual cells.
In addition, the model of Shirinifard et al. (2009) represents deformation of
cells by using the concept of Effective Energies. This concept is as well widely-
used in off-lattice models for representation of cell movement, deformation and
interaction.
14
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4 Original Model
In this chapter, a short review of the original modeling framework by Imig
et al. (2015) is presented. At first, the ODE model representing the intracellular
reaction to TRAIL stimulation is described in Section 4.1. The following section
reviews the simulation algorithm of the in silico model.
The original modeling framework represents a heterogeneous cell population,
wherein intracellular protein dynamics are simulated in detail. Heterogeneity of
cells is represented with focus on gene expression and cell cycle phases. The
simulation reproduces a response behavior of the cell population to extrinsic,
constant stimulation by TRAIL. Inheritance, cell division and cell death are
considered as well. Whereas irreversible changes, as mutations within the
population, direct cell-to-cell communication and morphological influences are
neglected.
The modeling framework is able to realistically represent short-term and
long-term response behavior of cell populations. It enables efficient analysis
and simulation of population dynamics as well as state trajectories of single
cells. For further reading, Imig et al. (2015) is recommended.
4.1 Intracellular ODE Model
As ODE model for protein signaling dynamics within a cell, the model by
Eissing et al. (2004) is used in the original modeling framework. The model
C3:IAP
C8*
C3
C3*IAP
+
+
Figure 4.1: Original reaction network
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reproduces the extrinsic apoptosis signaling pathway triggered by death receptor
stimulation within a cell. The complex apoptotic signaling process is reduced to
an elementary form, which is nevertheless able to reproduce key characteristics
as bistability and a fast execution phase combined with prolonged lag phases.
Consequently, this model can represent fast kinetics at the single cell level as
well as slower dynamics observed in cell populations. The initial distribution
of proteins are chosen heterogeneously within the population which results in
individual response of cells to extrinsic stimulation.
In the following, the reaction network of the model is described. It consists
of eight reactions and seven species and is illustrated in Figure 4.1. The species
C8 represents both initiator procaspases 8 and 10. C3 stands in general for the
executioner procaspases, e.g. 3, 6 and 7. The activated form of caspases are
represented as C3∗ and C8∗. Inihibitor of apoptosis protein (IAP ) represents
the proteins XIAP, cIAP-1 and cIAP-2. Whereas CARP is a caspase 8- and
10-associated RING protein. The species C3 : IAP and C8∗ : CARP are
complexes of the integrated proteins.
The model input is a stimulus of the receptor represented by C8∗ molecules.
The choice of C8∗ molecules as model input is caused by incomplete knowledge
respective the molecular events occurring around death-inducing signaling
complexes (DISCs). First, C8∗ cleaves and activates C3. Further, C3∗ enhances
the activation of C8. This reaction operates as positive feedback loop, whereat
the effect of procaspase 6 is neglected. Moreover, the species CARP and IAP
both act as inhibitors by binding and cleaving C8∗ and C3∗. In this model the
exceeding of a threshold of C3∗ represents the following apoptosis machinery,
which is not simulated more detailed. The cleavage products of IAP and C3
are neglected. Furthermore, all species are continuously degraded, whereas C3,
C8, IAP and CARP are additionally synthesized. All described reactions are
based on mass action kinetics.
Summarized the described reaction network of Eissing et al. (2004) is a very
reduced system description, but nevertheless able to appropriately represent
apoptosis signaling pathway. Further, the simplicity enables intense mathe-
matical analysis within a wide range of parameters. For detailed discussion of
mathematical analysis Eissing et al. (2004) is recommended. Hence, this ODE
model is well suitable for application in the simulation.
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Population constructor:
cells: vector with 
mother cells 
Minimal simulated
time in
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Figure 4.2: Scheme for the original simulation algorithm. Adapted from Imig
et al. (2015)
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4.2 Simulation Algorithm
This section decribes the structure of the original simulation algorithm Imig
et al. (2015) illustrated in Figure 4.2. At the beginning of the simulation, the
heterogeneous cell population is constructed. Therefore, a list called cells is
declared which contains the mother cells. In the following, the population is
simulated from t0 until tend. For this purpose, the cell with minimal simulated
time is chosen and its protein dynamics is calculated with the reaction network
introduced in Section 4.1. It is simulated until the minimuml the time of next
division tdivision and tend is reached, the model input changes or the death
condition is met. If a threshold of C3∗ is reached, the reaction network fulfills
the death condition and the cell is deleted from cells. If otherwise the network is
simulated until tdivision, the cell divides. Therefore, a daughter cell is appended
to cells and if the maximal number of cells (Nmax) is exceeded, a random cell
is removed. Hereupon, the simulation of one cell is completed for a cell cycle.
In the following, all cells are simulated in the same manner until the end of
population simulation tend is reached. For further information on the simulation
algorithm Imig et al. (2015) is proposed.
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Experiments revealed a differing reaction of three-dimensional populations to
treatment with TRAIL in contrast to the two-dimensional case, see Section
1. Three-dimensional in vitro models showed an emerging resistance. The
main hypotheses are: reduced TRAIL concentration inside the MCTS and
modified proliferation resulting from limited nutrient supply. This chapter
presents the mathematical model extended with a spatial component to consider
the characteristics of three-dimensional tumor spheroids leading to increased
TRAIL resistance.
In the first section, MCTS as simulation object is defined. The following
sections present the modeling of TRAIL and nutrient dynamics in a spheroid.
The model is split into two levels. Firstly, the flow of TRAIL and glucose in
the intercellular space of the tumor spheroid is simulated. This model of flow is
implemented via reaction-diffusion equations presented in Section 5.2. Secondly
on the cellular level, intracellular reactions following the uptake of TRAIL
and nutrients into a tumor cell are considered. To implement the intracellular
dynamics of TRAIL, the original reaction model 4.1 is extended and coupled to
the extracellular dynamics, see Section 5.3.1. The growth rate depends linearly
on the uptake of nutrients which is described in Section 5.3.2.
5.1 Biological System
As simulation object, a MCTS introduced in Section 3.1, is chosen. More
precisely, an avascular tumor spheroid without a necrotic core is modeled. In
experiments a necrotic core occurs when the MCTS exceeds a radius of 200µm.
Hence, the tumor spheroid is simulated up to a maximum radius of 200µm,
which correlates with 20 cell layers.
The used experimental data and hypotheses were established at the Institute
of Cell Biology and Immunology of the University of Stuttgart. This specific
MCTS is an appropriate choice for this work, because the institute is able to
generate and test it, while it is a realistic in vitro model for tumor micro regions
as discussed in Section 3.1. This enables a validation and verification of the
results of the extended simulation model.
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5.2 Model of Extracellular Substrate Dynamics
This section presents the theoretical model of TRAIL and nutrient dynamics in
the extracellular space of the tumor spheroid which is developed in this thesis.
The model describes the flow of the substrates TRAIL and glucose within the
intercellular space of a tumor spheroid. In Section 5.2.1, the equations for
the dynamics of TRAIL adapted from Goodman et al. (2008) are described.
The system of equations consists of one partial and three ordinary differential
equations. The reaction-diffusion equation derived in Section 5.2.2 is a partial
differential equation and describes glucose dynamics in the intercellular space.
For simulation, the spatial dimension of the tumor population is considered.
Since the detailed shape and structure of the tumor spheroid is not in focus,
the spheroid is assumed to be radial symmetric. More precisely, tumor cells
are regarded as spheres in a crystalline arrangement, so that the population
can be portioned into cell layers. Cells with the same distance to center form
a layer. The occupation of a cell layer is described as density and assumed
to be homogeneous within a layer. The approximation of tumor structure is
reasonable, since the detailed shape is irrelevant concerning the problem of
multicellular resistance to treatment with TRAIL.
The tumor spheroid is regarded continuously porous in terms of the theory
of porous media presented in Ehlers (1996). In this theory, the complex
diffusion process, which takes place in the intercellular space, is replaced by a
homogeneous flow through a continuum. This virtual flow is called Darcy flux.
There are various approaches in the context of tumor spheroid modeling, as
Goodman et al. (2008) and Sciumè et al. (2013), using the theory of porous
media.
This diffusion dynamic is modeled with the second law of diffusion by Fick
(1855) in one spatial dimension x:
∂C
∂t
= ∂
∂x
[
D
∂C
∂x
]
(5.1)
The diffusive transport of substrate through a tumor spheroid by Brownian
motion is driven by a difference of concentration C. The substrate flows from
regions with high concentration to regions with lower ones. In this equation
from Grathwohl (1998),
D = εδ
τ
D0 (5.2)
is the effective diffusion coefficient which measures mobility of the diffusive
substrate. In terms of the theory of porous media, the effective diffusion
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Figure 5.1: Extracellular reaction network
coefficient is a function of the porosity ε, the tortuosity τ and the constrictivity
δ. Due to experimental difficulties, values of these parameters in tumor spheroids
are predominantly unkown.
5.2.1 Extracellular TRAIL Dynamics
Goodman et al. (2008) presents a theoretical model of particle diffusion into
spheroids including particle binding and association at the cell surface. In
this work, the model by Goodman et al. (2008) is adapted to the simulation
of TRAIL dynamics in the intercellular space of a tumor spheroid. In the
intercellular space, the diffusion of TRAIL molecules as well as their binding to
death receptors DR and the following activation of DR : T -complexes (CO) is
simulated. The reaction chain is visualized in Figure 5.1. The time-dependent
dynamics of TRAIL
∂CT
∂t
= 1
r2
∂
∂r
[
DT (ε)ε(ρ)r2
∂
∂r
[
CT
ε
]]
(5.3)
+
(
k−1CO − k1CT NAV
ε
DR
)
zε
NAV
is modeled as molar concentration CT [moll ]. In this equation, r is the radial
direction and t is the time variable. CT is the concentration of TRAIL molecules
in the spheroid volume and CT
ε
is the concentration in the accesible intercellular
space. z is the number of cells per cell layer, NA is Avogadro’s number and V
is the extracellular space per cell. These three constants are used to transform
molar concentration to molecule amount and the other way around. In this
equation, non-uniformity of the spheroid is considered via the porosity ε. In
Goodman et al. (2008), ε varies in radial direction, since different values of
porosity have been determined for the proliferating and the necrotic regions. In
this work, the effective porosity
ε(ρ) = ε0ρ+ (1− ρ) (5.4)
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is assumed a function of density ρ(r) which also varies in radial direction r.
The porosity ε0 measures the share of a spheroids volume which makes up
intercellular space in a region which is most dense (Goodman et al., 2008). As
it includes effects of the extracellular matrix, ε0 cannot be calculated exactly
but is determined experimentally. ε(ρ) is a sum of the free space due to low
cell density and the intercellular space. The effective porosity in regions with
high density equals ε0 and grows with decreasing ρ up to 1.
The effective diffusion coefficient
D(ε) = εmD0 (5.5)
is determined in dependence of D0, ε and m ≥ 0. This equation is empirical and
taken from Grathwohl (1998). It is chosen as it connects the effective diffusion
coefficient directly with the porosity. The parameter m controls the porosity-
dependent variation of D. For m = 1, the effective diffusion coefficient varies
with factor 10 between most-dense regions and regions with low cell density.
The effective diffusion coefficient can theoretically be measured, however in
practice, experimental difficulties lead to rare knowledge of diffusion coefficients
in tumor tissue.
The dynamics of death receptors DR, complexes CO and activated complexes
CO∗ are adapted from Aldridge et al. (2011) with the following ordinary
differential equations using mass action kinetics:
∂DR
∂t
= k−1CO − k1DR · T + ksDR− kdDR (5.6)
∂CO
∂t
= −k−1CO + k1DR · T − k2CO − kdCO (5.7)
∂CO∗
∂t
= k2CO. (5.8)
Figure 5.1 shows the reaction chain. The ODEs are calculated in molecule
amounts per cell, so that rate values from Aldridge et al. (2011) can be used for
the association rate k1, dissociation rate k−1 and the activation rate k2. The
Synthesis rate ks of DR and the degradation rates kd of DR and CO are as
well taken.
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The initial and boundary conditions of CT
CT (0,r) =

CT (0,1) ε(t,0)ε(t,0)+(ρ(1)−ρ(0))·(ε0−1) for r = 0
0 for r(0, rx)
ε(0,r) · C0T for r[rx, R]
(5.9)
CT (t,0) = CT (t,1)
ε(t,0)
ε(t,0) + (ρ(1)− ρ(0)) · (ε0 − 1) (5.10)
⇐⇒ ∂
∂r
[
CT (t,0)
ε(t,0)
]
= 0
CT (t,r) = ε(t,r) · C0T for r[rx, R]. (5.11)
are given for the simulated area [0, R] with 0 ≤ rx < R. rx is the radius of the
outermost layer of the simulated spheroid. The simulated area is chosen major
the simulated spheroid as during simulation the spheroid’s size changes.
Initially, concentration of TRAIL is maximal in the surroundings of the
spheroid (rx, R] and in the outermost layer with radius rx. Inside the spheroid
[0, rx), the concentration of TRAIL is initially zero.
The boundary condition for the outermost layer (5.11) is a Dirichlet condition,
whereas at the most inner layer (5.10), it is a Neumann. The Neumann condition
is chosen analog to Goodman et al. (2008).
For death receptors per cell, complexes and activated complexes the initial
conditions are
DR(0,r) =
{
10 000 r ≤ rx
0 r > rx
(5.12)
CO(0,r) = 0 ∀r (5.13)
CO∗(0,r) = 0 ∀r. (5.14)
These initial conditions are given in molecule amount. The initial amount of
DRs per cell is approximated by the Institute of Cell biology and Immunology.
5.2.2 Extracellular Glucose Dynamics
For simulation of nutrient supply, glucose is assumed to be the most critical
nutrient for proliferation of cells in a tumor spheroid. The reason is its limited
mobility in tumor tissue compared to smaller molecules like oxygen. More
nutrients are theoretically easy to add, but due to missing experimental values
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of diffusion coefficients in tumor tissue and uptake rates into tumor cells not
implemented for now. There exist approaches modeling two or more nutrients
within a spheroid, e.g. Schaller & Meyer-Hermann (2005).
Michaelis-Menten kinetics as presented in Michaelis & Menten (1913) describes
the uptake rate of glucose
kU (c) = c
kmax
Km + c
(5.15)
as a function of the extracellular concentration c of glucose. In this equation
kmax is the maximum uptake rate into a cell and Km is the Michaelis-Menten
constant, which is the concentration where half of the maximum uptake rate
is reached. The rate kU as a function of c is described by a saturation curve
which converges for high concentrations to kmax. Experimental studies, like
Natarajan & Srienc (1999), prove that Michaelis-Menten kinetics adequately
models the uptake of glucose into a cell.
The time-dependent dynamics of glucose concentration CG
∂CG
∂t
= 1
r2
∂
∂r
[
DG(ε)ε(ρ)r2
∂
∂r
[
CG
ε
]]
− z · CG
ε
kmax
Km + CGε
(5.16)
is a combination of the glucose uptake by z cells and the diffusive transport.
The diffusion dynamic is modeled similar to 5.3 and taken from Goodman et al.
(2008).
The corresponding initial and boundary conditions for glucose concentration
are
CG(0,r) = CssG (r) ∀r (5.17)
CG(t,0) = CG(t,1)
ε(t,0)
ε(t,0) + (ρ(1)− ρ(0)) · (ε0 − 1) (5.18)
⇐⇒ ∂
∂r
[
CG(t,0)
ε(t,0)
]
= 0
CG(t,r) = ε(t,r) · C0G for r[rx, R]. (5.19)
The boundary conditions (5.18,5.19) are the same as for TRAIL dynamics. The
steady state concentration of glucose CSSG is chosen to be the initial concentration
within the spheroid. It is determined via
∂CG
∂t
= 0 (5.20)
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which equals the balance between glucose uptake and diffusive transport.
For simulation of the extracellular substrate dynamics, a system of two partial
differential equations, 5.3 and 5.16, and three ordinary differential equations, 5.6,
5.7 and 5.8, are calculated. The dynamics of CO∗ (5.8) and the uptake rate of
glucose kU (5.15) make up the interface between extracellular and intracellular
model.
5.3 Model of Intracellular Substrate Dynamics
This section presents the intracellular dynamics following the uptake of TRAIL
and glucose. In the original model concentrations of TRAIL and glucose are
assumed homogeneous in space. This assumption results in a homogeneous
growth rate and stimulation by TRAIL in population. In contrast in a three-
dimensional spheroid, concentrations of TRAIL and glucose are heterogeneous
and time-dependent. The intracellular reactions leading to modified cellular
response to TRAIL are presented in the first part of this section. In the second
part, a function is described which models the relation between the glucose
uptake to a cell and its growth rate.
5.3.1 Intracellular TRAIL Dynamics
The original ODE model 4.1 is extended to enable a heterogeneous stimulation
with TRAIL. For that purpose, the model input representing this stimulation
is changed and the reaction network is expanded with six reactions and four
species. The added reactions and species are adopted from Aldridge et al.
(2011), a commonly used and tested model. The extended reaction network is
illustrated in Figure 5.2.
In the original model, the model input is given in form of C8∗ molecules. Due
to the nonlinear relation between TRAIL stimulation and activation of C8, it is
not possible to stimulate the tumor cells individually within the original model.
The model input is changed to activated complex molecules CO∗. Its signal
strength is determined via the input rate
kI =
4CO∗
4t (5.21)
which is calculated from the amount of activated molecules 4CO∗ per interval
4t. The rate kI connects the extra- and intracellular reaction dynamics and
is constant in an interval. The amount of activated molecule complexes CO∗
follows from the extracellular dynamics (5.8). Intracellular reactions follow to
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Figure 5.2: Extended reaction network. The original reaction network is
extended with extracellular and intracellular reactions. The species CO∗ acts
in extracellular space as well as in intracellular space. All species exept T are
degraded, whereas C8,C3, IAP , CARP , FLIP are DR continuously synthe-
sized.
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the activation of CO as illustrated in Figure 5.2. Activated complexes CO∗
bind and activate C8. The species FLICE-like inhibitory protein (FLIP) acts
as inhibitor for CO∗ by binding and cleaving it. All species are continuously
degraded. FLIP is continuously synthesized. Therefore, reaction, production
and degradation rates are taken from Aldridge et al. (2011).
5.3.2 Intracellular Glucose Dynamics
Intracellular reactions following the uptake of glucose are not modeled in detail.
Instead, a linear relation is deduced representing the growth rate of a cell as
a function of glucose uptake. The rate of glucose uptake into one cell 5.15 is
modeled with Michaelis-Menten kinetics. The growth rate of cells in relation
to the extracellular substrate concentration is as well often modeled with a
Michaelis-Menten kinetics. This approach of Monod (1949) is appropriate to
describe growth dynamics of cell populations. In this work, the growth rate as
function of the uptake rate kU (5.15)
g(kU ) = max
(
gmin, gmin + gmax−gminkmax−kmin (kU − kmin)
)
(5.22)
for kU [0,kmax]
is bounded above by the limitation of the uptake rate kmax resulting in gmax,
the maximal growth rate. A limit below is set with regard to simulation, during
which g must be positive. kmin is the uptake rate which is assumed for cells
within the 21st layer. Cells with an uptake rate smaller than kmin are necrotic
due to insufficient nutrient supply and not simulated in this work.
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6 Implementation of Simulation Algorithm
This chapter introduces the extended simulation algorithm. In the first section,
the numerical approximation of the system of differential equations derived in
Section 5.2 is presented. In Section 6.2, the necessary modifications are argued,
therefore the extension to a three-dimensional population and the division of
simulation into intervals is discussed. The structure of the algorithm is described
in Section 6.3 and illustrated in Figure 6.1.
6.1 Numerical Solution
In this section, the numerical solution of extracellular substrate dynamics, as
described in Section 5.2, is presented.
At first, the simulated area is discretized in spatial dimension. Therefore,
it is split in cell layers with discrete radius r and constant thickness 4r in
terms of the finite difference method. Within one cell layer the concentration of
glucose and TRAIL is assumed constant. For further information on the finite
difference method, Schwarz & Köckler (2011) is recommended.
As merely the diffusive terms of the reaction-diffusion equations for TRAIL
and glucose (5.3) and (5.16) include spatial derivatives, the finite difference
approximation is restricted to these terms. To enable application of the finite
difference method, the diffusive term is transformed:
1
r2
∂
∂r
[
D(ε)ε(ρ)r2 ∂
∂r
[
C
ε
]]
(6.1)
= ∂D
∂r
ε
∂
∂r
[
C
ε
]
+D∂ε
∂r
∂
∂r
[
C
ε
]
+ 2
r
Dε
∂
∂r
[
C
ε
]
+Dε ∂
2
∂r2
[
C
ε
]
= mD0(ε0 − 1)∂ρ
∂r
εm
∂
∂r
[
C
ε
]
+D(ε0 − 1)∂ρ
∂r
∂
∂r
[
C
ε
]
+ 2
r
Dε
∂
∂r
[
C
ε
]
+D
(
∂2C
∂r2
− 2
ε
(ε0 − 1)∂ρ
∂r
∂C
∂r
− C
ε
(ε0 − 1)∂
2ρ
∂r2
+ 2C
ε
(ε0 − 1)2
(
∂ρ
∂r
)2)
with ∂
∂r
[
C
ε
]
= 1
ε2
(
∂C
∂r
ε− (1− ε0)∂ρ
∂r
C
)
(6.2)
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In the following, the first spatial derivatives ∂ρ
∂r
and ∂C
∂r
are replaced by the
first-order central difference (Schwarz & Köckler, 2011):
∂x
∂r
≈ x(r + 1)− x(r − 1)24r (6.3)
In addition, the second spatial derivatives ∂
2ρ
∂r2 and
∂2C
∂r2 are replaced by the
second-order difference (Schwarz & Köckler, 2011):
∂2x
∂r2
≈ x(r − 1)− 2x(r) + x(r + 1)(4r)2 (6.4)
For solving the set of discretized equations at discrete time points t two
different methods are implemented. On the one hand, the explicit Euler method
is implemented. For this method regular time intervals 4t are chosen, wherein
4C, 4DR, 4CO, 4CO∗ are computed. The value X at time point t+ 1
Xt+1 = Xt +4X (6.5)
is determined from the value at time point t. Further informations on the
explicit Euler method are given in Zulehner (2011).
On the other hand, a method based on backwards differentiation formulas
(BDF) with adaptive step size is implemented. For further information on this
method, the SUNDIALS library (http : //sundials.wikidot.com/bdf −method)
is recommended.
6.2 Modifications
For simulation of the three-dimensional model, the algorithm is modified and
extended. First, the population is extended to a spatial dimension. The original
population is portioned into cell layers and the population is extended with the
variables density and radius. The variable radius assigns each cell a layer and
the variable density stores the occupation of cell layers. Since the space within
a layer is limited, proliferation can lead to sliding of tumor cells within the
spheroid. The daughter cell arises in the layer of its mother cell and if this layer
is fully occupied, a random cell from the layer is relocated to a neighboring layer.
This is proceeded within each affected layer until a subtotal occupied layer is
reached. Weather the cells are moved inwards or outwards is randomly decided
with a probability of 70:30 (inwards:outwards). This procedure guarantees, that
resistent genetic mutations occuring in one cell layer not unnaturally spread to
distant layers.
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Further, the simulation of extracellular TRAIL and glucose dynamics is added.
The presented system of differential equations from Section 5.2 are calculated
as presented in Section 6.1 to simulate the flow of TRAIL and glucose within
a tumor spheroid. This simulation results in a heterogeneous distribution of
TRAIL and glucose in the spheroid. The modified extracellular TRAIL and
glucose dynamics are dependent on density. As a result, death and division of
a cell directly influences the extracellular flow of substrate. This increased or
decreased flow affects the other cells in this layer.
These variations demand the simulation of population to pass of in the real
temporal order. In the original simulation the temporal order of the events are
not considered, as events do not influence other cells. Since the temporal order
of events is not predictable prior simulating intracellular dynamics of all cells,
an approximation is implemented. The simulation of population is split into
intervals. Each interval represents a time period within events pass in random
order and the number of events is restricted. This guarantees an approximately
real temporal order of events over the whole simulation. The order of events
converges to the real order, when scaling down the length of one interval. Per
interval and cell layer, constant values for the growth rate g¯ and the rate of
model input k¯I are used, since constant values are required for the original
population simulator. Mean values
x =
∑
i
xi
n
(6.6)
are calculated using xi, the value at every time step ∆t and n, the amount of
time steps.
6.3 Structure
In this section, the structure of the simulation algorithm is described and
illustrated in Figure 6.1. In the beginning of the simulation a three-dimensional
population is constructed. Next, the time for population simulation is split into
regular intervals.
The simulation of one interval begins with the calculation of the extracellular
dynamics of TRAIL and glucose assuming a constant density. As the population
simulator needs constant values, mean values for the rate of model input and
growth rate for each cell layer are determined.
Next, the population is simulated for the current interval with the constant
rate of model input and the constant growth rate per cell layer. Thereby the
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Simulate glucose and 
TRAIL dynamics 
for next interval
Simulate Population for current interval
with constant density, growth rate g 
and rate of model input kU
Is  tend 
reached ?
Construct 3D Population
cells: vector with mother cells
density: vector with occupation
of cell layers
Split time for population simulation
into intervals
Calculate mean growth rate g
and rate of model input kU
 for current interval
Yes
Yes
No
Split interval
End
Is expected number of events in
 current interval > Nmax ? 
No
Figure 6.1: Scheme for the extended simulation algorithm
34
6.3 Structure
simulation proceeds like the original population simulation described in Section
4.2. Merely the variable density is updated past division or death. In the event
of division within a completely occupied layer, cells are slid one layer. If all
cells are simulated, the end of a interval is reached.
If the number of events in the last interval exceeded a treshold, the next
interval is split into regular parts. The following intervals are simulated in the
same manner until the end of the simulation tend is reached.
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7 Parameter and Validation
This chapter presents the parameters used for simulation and resulting simula-
tions which are proper for validation. In most cases, experimentally determined
parameters are taken from various research papers. However, some of those
experimentally determined values cause unrealistic simulation results. For
example, measured values for the diffusion coefficients resulted in physically
unrealistic high concentrations inside the spheroid in the simulation. On the
one hand, this could be caused from imprecise measuring and differing experi-
mental conditions. On the other hand, approximations assumed in the course
of mathematical modeling and numerical solution could cause those incorrect
results. These undefined parameters are varied and the simulation result is
fitted to experimental measurements. In the following sections, the resulting
parameter values and the related validation results are presented. Section 7.1
presents the parameter set for the dynamics of glucose and 7.2 presents the
parameter set for TRAIL dynamics.
7.1 Concentration of Glucose, Uptake Rate and Growth Rate
The set of parameters for glucose dynamics is summarized in Table 7.1. C0G
is the concentration of glucose in the spheroid’s environment. Its value is
chosen equivalent to experimental conditions at the Institute of Cell Biology
and Immunology. The parameters describing the tumor spheroid, the porosity
ε0 and the thickness of a cell layer 4x are the same for simulation of TRAIL
and glucose dynamics. The value for the porosity of the spheroid ε0 is taken
from Goodman et al. (2008). The Michaelis Menten constant for glucose uptake
Km is taken from Li (1982).
The values for DG and kmax are adapted, since the experimentally determined
values of Casciari (1988) and Li (1982) result in a steady state distribution
whithout reduction of concentration inside the spheroid. Therefore, a most
dense spheroid with 20 cell layers is simulated. With the fitted values of DG and
kmax, a steady state distribution illustrated in Figure 7.1 is reached after about
2,5min. The value in the center of the spheroid is ∼ 16C0G which is similar to
distributions found in Li (1982).
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Parameter Symbol Value
Concentration of glucose in
environment
C0G 11,1111mM
Effective diffusion coefficient of
glucose in a tumor spheroid
DG 2,3E − 10 m2s
Maximal rate for glucose uptake of
one cell
kmax 3E − 8 molcell∗s
Michaelis-Menten constant for
glucose uptake
Km 0,58mM
Maximal uptake rate of glucose kext 2,8512E − 08 molcell∗s
Minimal uptake rate of glucose kmin 2,27612E − 08 molcell∗s
Maximal growth rate gmax 6,5359E − 4 1min
Minimal growth rate gmin 2,8881E − 4 1min
Porosity of tumor spheroid ε0 0,1
Thickness of a cell layer 4x 1E − 5m
Table 7.1: Parameter set for glucose dynamic
The distribution of glucose uptake per cell illustrated in Figure 7.2 is calculated
from the steady state concentration CSSG . kext is the uptake rate in the outermost
layer and kmin is the critical uptake rate per cell which shows up in the 21st
layer. The growth rate is linearly linked to the rate of glucose uptake. The
maximal growth rate gmax equals the growth rate of a cell in a two-dimensional,
monolayer population. It corresponds with 17,6754h per cell cycle. The minimal
growth rate gmin is equivalent to 40h per cell cycle.
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Figure 7.1: Steady state distribution of glucose concentration in a spheroid
with 20 cell layers
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Figure 7.2: Steady state rates of glucose uptake and cell growth in a spheroid
with 20 cell layers.
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7.2 TRAIL Concentration
Parameter Symbol Value
Effective diffusion coefficient of
TRAIL in a tumor spheroid
DT 3E − 14 m2s
Concentration of TRAIL in
environment
C0T 0,2nM
Extracellular volume per cell
accesible for diffusion
V 4E − 18 m3
l
Association rate k1 4E − 7 molecs·cell
Dissociation rate k−1 0,001 1s
Activation rate k2 5E − 5 1s
Porosity of tumor spheroid ε0 0,1
Thickness of a cell layer 4x 1E − 5m
Table 7.2: Parameter set for TRAIL dynamics
Table 7.2 shows the parameter set used for simulation of TRAIL dynamics.
The concentration of TRAIL in environment C0T is chosen equivalent to exper-
imental conditions. Association rate k1, dissociation rate k−1 and activation
rate k2 are taken from Aldridge et al. (2011).
The diffusion coefficient DT is adapted since the experimental determined
diffusion coefficient of Albumin in tumor spheroids of Davies et al. (2002)
resulted in obviously to fast diffusive transport in simulation. A spheroid with
20 fully occupied cell layers is simulated for 24h and 96h. Thereby, only the
diffusion without the reaction is simulated, so that the concentration inside the
spheroid can be fitted to experiments of Albumin diffusion into tumor spheroids
as seen in Fessl (2013). Figure 7.3 presents the resulting TRAIL concentrations
after 24h and 96h.
V , the extracellular space per cell could be theoretically calculated from the
volume of a spheroid and the effective porosity, but due to imprecise values,
it is adapted. As V influences the transformation of molar concentration
into molecule amounts, its exact determination is important. Therefore a
two-dimensional population is extended with the dynamics of DR, CO and
CO∗ and its behaviour under treatment with TRAIL is fitted to experiments
with monolayers under TRAIL treatment. The used experimental data was
established by Fabian Richter for the Institute of Cell Biology and Immunology
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and has not been published yet. Figure 7.4 shows the result of fitting.
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Figure 7.3: Concentration of TRAIL after 24h and 96h diffusion
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Figure 7.4: Monolayer under TRAIL treatment with extended intracellular
ODE model. The used experimental data (unpublished) shows one exemplary
measurement of the cell line HCT-116 and was established by Fabian Richter
for the Institute of Cell Biology and Immunology.
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8 Analysis and Simulation
In this chapter, the simulation is analyzed and simulation results are presented.
In the first section, the computiational effort of a three-dimensional simulation
is analyzed and compared to the two-dimensional one. At first, the computa-
tional effort due to simulation of nutrient and TRAIL dynamics is described.
In the next step, the computational effort due to changes in the simulation
algorithm, mainly the division of simulation into intervals is analyzed. Section
8.2 presents simulation results comparing the reaction of a 2D population and
a 3D population to TRAIL stimulation.
8.1 Analysis of Computational Effort
The computing effort due to simulation of nutrient and TRAIL dynamics is
analyzed at first. Therefore, diffusion-reaction dynamics of TRAIL and glucose
in a spheroid of 20000 cells are simulated for 1h. Each dynamic is simulated
with the two numerical methods described in Section 6.1. All simulations
are executed on a computer with 12 Cores and 32 GB RAM. The required
computing times are presented in Table 8.1.
TRAIL dynamic Glucose dynamic
explicit method 133,1376 s 9,5992 s
bdf method 60,3578 s 34,6742 s
Table 8.1: Computing time of reaction-diffusion dynamics
The explicit method produces different computing times of TRAIL and
glucose dynamics caused by the different choice of temporal step sizes 4t. For
simulation of glucose diffusion, a fixed step size of 4t = 6e−2 s is used, whereas
TRAIL dynamic is simulated with a step size of 4t = 6e− 3 s. The fixed step
size is chosen with regard to the convergence of solution. This convergence is
dependent on the diffusion coefficient and the spatial step size, as well as on
the simulation period and the growth dynamics of population.
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The bdf method uses adaptive step sizes. This results in reduced computing
times of TRAIL dynamics compared to the explicit method. The computational
effort of glucose dynamics with the bdf method is increased compared to the
explicit method. In addition, the distribution of concentration is approximated
more exactly than the one with the explicit method. A probable reason for
the different effect of the bdf method on TRAIL and glucose dynamics, is
that TRAIL dynamic requires step sizes within a greater range. Further, the
computing times of glucose dynamics with bdf method are higher than TRAIL
dynamics. This is caused by faster dynamics of glucose diffusion compared to
TRAIL diffusion.
In the following, the change of computational effort due to changes in the
simulation algorithm are analyzed. Therefore, a three-dimensional simulation
is executed in various amounts of intervals. A population of 20000 cells is
simulated for 24h with stimulation by TRAIL. The required computing times
are given in Table 8.2.
Number of intervals Computing time
1 128,2633min
2 136,0378min
10 143,6203min
100 279,4758min
1000 1528,9925min
Table 8.2: Computing time of intervals
The split of simulation into intervals increases the computational effort. The
increase is clearly observable from 100 intervals rising.
8.2 Simulation
In this section, the result of one exemplary simulation is presented. A population
of 5000 cells is simulated for 72h under TRAIL treatment. It is simulated in
two dimensions as well as in three dimensions. The results are illustrated in
Figure 8.1.
At the end of the three-dimensional simulation, about 39700 cells are alive,
whereas 12400 cells have died during treatment with TRAIL. The three-
dimensional simulation compared to the two-dimensional one shows an increased
resistance to treatment with TRAIL. The resulting concentration of TRAIL
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Figure 8.1: Comparison of Simulation in 2D and 3D. A cell population is
simulated for 72h in two dimensions and three dimensions with stimulation
by TRAIL. In addition, the three-dimensional population is simulated for 48h
without stimulation .
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Figure 8.2: TRAIL concentration in the spheroid after 72h simulation
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inside the spheroid after 72h simulation in three dimensions is shown in Figure
8.2. The extremely low concentration inside the spheroid explains the similarity
between the three-dimensional simulations with and without stimulation by
TRAIL. The simulation results in comparison to experimental data let assume
that not all simulation parameter are chosen correctly. Experimental work by
Daniela Stöhr (Institute of Cell Biology and Immunology) showed an reduction
of three-dimensional populations of about 40− 75 % after 24h stimulation by
0.1nM TRAIL (unpublished data). This reduction of cell amount cannot be
observed in simulation. One hypotheses is that the real diffusion dynamic of
TRAIL is faster than assumed in simulation. Important parameters which
should be adapted are the diffusion coefficient of TRAIL DT and the minimal
growth rate gmin.
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In this thesis, a three-dimensional mathematical model of substrate diffusion
into a spheroid is derived as well as an extension of an agent-based simulation
framework. The mathematical model representing the diffusion of TRAIL and
glucose into a multicellular spheroid is based on reaction-diffusion equations.
The spheroid is assumed radially symmetric and continuously porous in terms
of the theory of porous media. The model accounts for radially dependent
changes of cell density inside the spheroid which occur during simulation of the
population under medical treatment. The hybrid, agent-based simulation repre-
sents a simplified, three-dimensional population under treatment with TRAIL.
Therefore, the intracellular reaction to TRAIL and glucose uptake is simulated
as well as TRAIL and glucose dynamics in the intracellular space. For numerical
solution of the mathematical model during simulation different methods are
implemented. The derived model is elementary adapted to experimental data
of diffusion into spheroids. However, for a realistic adaption, more experimental
data is necessary. The definite determination of all parameters is not part of
this thesis.
In conclusion, the adapted model can be used to analyze the effect of TRAIL
and glucose dynamics to multicellular resistance. In addition, the characteristics
of 3D populations after stimulation by TRAIL can be analyzed.
In further research, the model could be adapted to equivalent experimental
data. The realistic representation of TRAIL concentration in the spheroid
is considered most important. Therefore, more experimental research about
TRAIL diffusion in various areas of a spheroid is necessary. In addition, it
could be necessary to extend the model with extracellular matrix components
to realistically represent TRAIL dynamics in the spheroid.
Further, the model could be extended with intercellular communication
increasing pro-apoptotic signals in the spheroid. This could be another possible
reason for the increased resistance of three-dimensional populations to TRAIL
stimulation. In course of this extension, the parallel implementation of contact
inhibition of growth as seen in Schaller & Meyer-Hermann (2006) is proposed.
This could as well result in a more realistic growth behaviour of the spheroid.
In the next step, the computing capacity of the simulation could be improved.
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Therefore, the choice of the numerical method should be reviewed.
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